Gabelli & CO Investment Advisers, Inc. Pacific Biosciences Of California, Inc. Transaction History

Gabelli & CO Investment Advisers, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 06, 2020	SELL	$3.61 - $9.87 $2.65 Million - $7.24 Million	-733,892 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$2.65 - $4.03 $575,201 - $874,739	-217,057 Reduced 22.83%	733,892 $2.53 Million
Q1 2020 May 14, 2020	BUY	$2.36 - $5.26 $84,547 - $188,439	35,825 Added 3.91%	950,949 $2.91 Million
Q4 2019 Feb 14, 2020	SELL	$4.6 - $5.57 $1.78 Million - $2.16 Million	-387,267 Reduced 29.74%	915,124 $4.7 Million
Q3 2019 Nov 01, 2019	SELL	$4.99 - $6.16 $48,981 - $60,466	-9,816 Reduced 0.75%	1,302,391 $6.72 Million
Q2 2019 Aug 02, 2019	BUY	$5.92 - $7.41 $610,310 - $763,919	103,093 Added 8.53%	1,312,207 $7.94 Million
Q1 2019 May 02, 2019	BUY	$6.8 - $7.4 $4.9 Million - $5.33 Million	720,064 Added 147.24%	1,209,114 $8.74 Million
Q4 2018 Jan 30, 2019	BUY	$3.99 - $7.82 $1.95 Million - $3.82 Million	489,050 New	489,050 $3.62 Million

259

255M

3.05M

1.71M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $295M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Gabelli & CO Investment Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Gabelli & CO Investment Advisers, Inc. with notifications on news.